April 4, 2024 — Osso VR, a leader in immersive procedural training, announces the release of a co-developed curriculum ...
April 4, 2024 — A new study found increased coronary vessel wall thickness that was significantly associated with ...
April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com: 1. CLS Health ...
April 3, 2024 — GE HealthCare announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid ...
April 3, 2024 — - Eko Health, a pioneer in applying artificial intelligence (AI) for early detection of heart and lung ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
April 3, 2024 — In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization ...
April 3, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex and Arrow International are ...
April 2, 2024 — A woman’s cardiovascular risk can rise sharply after she goes through menopause, quickly catching up to ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
April 2, 2024 — Individuals with heart disease stand to gain the most from a low sodium diet but, on average, consume ...
April 2, 2024 — Medical device technology developer Concept Medical has announced it has been granted Investigational ...
April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
April 2, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) approved the company's first-of-its ...
April 1, 2024 — Esperion announced that the United States Food and Drug Administration (FDA) has approved broad new ...
April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...
April 04, 2024
